With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Here’s an intriguing review on how CRISPR technology is fast-tracking Big Pharma’s next billion dollar investment by systematically reviewing the impact of deleting each and every 18K-some-odd cancer cell-line genes one at a time. | Hahn, N Engl J Med 2019